Houston, Texas — According to state and local development sources, United Therapeutics Corporation plans to invest $96 Million to build out 77,448 square feet of new space in Houston. The company plans to occupy the new space at 11848 Common Dock Dr. in Houston, on or about September 1, 2026. According to the company website United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. We currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! Our employees can be found collaborating across the United States, Europe and Asia. As a group, we are relentless in our pursuit of medicines for life and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #WeAreUnitherians

To learn more about United Therapeutics Corporation, visit http://www.unither.com/

Company Contact:
Martine Rothblatt, Chief Executive Officer
mrothblatt@unither.com
301-608-9292

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.